dc.contributor.author | Hay, Elizabeth A. | |
dc.contributor.author | McEwan, Andrew | |
dc.contributor.author | Wilson, Dana | |
dc.contributor.author | Barrett, Perry | |
dc.contributor.author | D'Agostino, Giuseppe | |
dc.contributor.author | Pertwee, Roger G. | |
dc.contributor.author | MacKenzie, Alasdair | |
dc.date.accessioned | 2019-09-11T09:50:06Z | |
dc.date.available | 2019-09-11T09:50:06Z | |
dc.date.issued | 2019-11 | |
dc.identifier | 147505465 | |
dc.identifier | 39218959-ad65-40c7-a319-33523c2b17fe | |
dc.identifier | 85070874603 | |
dc.identifier | 31445429 | |
dc.identifier | 000498331200031 | |
dc.identifier.citation | Hay , E A , McEwan , A , Wilson , D , Barrett , P , D'Agostino , G , Pertwee , R G & MacKenzie , A 2019 , ' Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour ' , Psychoneuroendocrinology , vol. 109 , 104407 , pp. 104407 . https://doi.org/10.1016/j.psyneuen.2019.104407 | en |
dc.identifier.issn | 0306-4530 | |
dc.identifier.other | Mendeley: e4663339-4fc2-3b83-b0e6-4bdb3f61dade | |
dc.identifier.other | PubMedCentral: PMC6857436 | |
dc.identifier.other | ORCID: /0000-0003-3604-2950/work/76975642 | |
dc.identifier.uri | http://hdl.handle.net/2164/12911 | |
dc.description | Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved. | en |
dc.format.extent | 8 | |
dc.format.extent | 1987378 | |
dc.language.iso | eng | |
dc.relation.ispartof | Psychoneuroendocrinology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Cannabinoid-1 receptor | en |
dc.subject | CRISPR genome editing | en |
dc.subject | gene regulation | en |
dc.subject | tissue specific | en |
dc.subject | enhancer | en |
dc.subject | polymorphisms | en |
dc.subject | ethanol intake | en |
dc.subject | CB1 agonists | en |
dc.subject | Win55 | en |
dc.subject | 212-2 | en |
dc.subject | pharmacogenetics | en |
dc.subject | Ethanol intake | en |
dc.subject | Pharmacogenetics | en |
dc.subject | Enhancer | en |
dc.subject | NICOTINE | en |
dc.subject | Gene regulation | en |
dc.subject | Tissue specific | en |
dc.subject | ENDOCANNABINOID SYSTEM | en |
dc.subject | Anxiety-related behavior | en |
dc.subject | Polymorphisms | en |
dc.subject | HIPPOCAMPUS | en |
dc.subject | Wln55,212-2 | en |
dc.subject | CB1 RECEPTORS | en |
dc.subject | HYPOTHALAMUS | en |
dc.subject | QH426 Genetics | en |
dc.subject | Endocrine and Autonomic Systems | en |
dc.subject | Psychiatry and Mental health | en |
dc.subject | Biological Psychiatry | en |
dc.subject | Endocrinology | en |
dc.subject | Endocrinology, Diabetes and Metabolism | en |
dc.subject | Other | en |
dc.subject | PhD-719-2013 | en |
dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
dc.subject | BB/N017544/1 | en |
dc.subject | Rural and Environmental Science and Analytical Services (RESAS) | en |
dc.subject.lcc | QH426 | en |
dc.title | Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Rowett Institute | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/j.psyneuen.2019.104407 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85070874603&partnerID=8YFLogxK | en |
dc.identifier.url | http://www.mendeley.com/research/disruption-enhancer-associated-addictive-behaviour-within-cannabinoid-receptor1-gene-suggests-possib | en |